Early data back Thoratec's HeartMate II as destination therapy
The HeartMate II left ventricular assist device (LVAS) developed by Thoratec is much more effective than a previous model, early trial results have shown.
Tuesday 9 December 2008

Two PET/CT scans better than one for breast imaging, but MRI is best
A study has found that dual-time point fluorodeoxyglucose (FDG) PET/CT scanning is more accurate at detecting breast cancer than one PET/CT scan.
Monday 24 November 2008

UK tackles poor climate for medtech trials with govt/industry agreement
The UK’s Department of Health and medical technology industry produces a model clinical investigation agreement (mCIA) for the sector, with the aim of speeding up the researching contracting process in the NHS, affecting all industry-funded projects.
Thursday 13 November 2008

AHA 2008: Drug-eluting stents beat bare metal stents in diabetics, new registry data show
Drug-eluting stents (DESs) are safer than bare-metal stents (BMSs) in diabetics, a large-scale registry has indicated. Our Science & Technology editor, Elizabeth Cairns, reports from New Orleans, Louisiana, USA.
Thursday 13 November 2008

AHA 2008: Angioplasty is more efficacious in Hispanic patients
Hispanic patients are much less likely to require reintervention following angioplasty, a trial has suggested. Elizabeth Cairns, Editor, Science & Technology, brings this report from New Orleans, Louisiana, USA.
Wednesday 12 November 2008

Interim data from "real-world" registry back use of Genous
Genous, the antibody-coated stent developed by OrbusNeich, could provide a safer alternative to drug-eluting stents (DESs), trial results suggest.
Tuesday 11 November 2008

Promising clinical results with Augment bone graft boost BioMimetic
A pilot clinical study has shown that the Augment Injectable bone graft developed by BioMimetic Therapeutics has achieved 100% bone fill in all the patients treated.
Wednesday 5 November 2008

Support grows for MRI in breast cancer
Giving MRI scans to breast cancer patients decreases the rate of mastectomies and does not delay treatment, a study suggests.
Monday 3 November 2008

Abbott's bioabsorbable DES dissolves within two years
A drug-eluting stent (DES) has been shown to be absorbed entirely after implantation into patients' blood vessels for the first time.
Wednesday 22 October 2008

Some patients at "substantially higher risk of death" with ICDs
Two new analyses of a large-scale clinical trial of implantable cardioverter-defibrillators (ICDs) suggest that patients given electric shocks by the devices appear to have an increased risk of death.
Monday 6 October 2008

Previous 1 2 Next